Pediatric Updates: Pharmacology: Psychopharmacology: 3rd Edition

Pharmacology: Psychppharmacology - 3rd Edition

PNCB's third edition of all new in-depth psychopharmacology CE includes 12 journal articles for your references. Whether you treat and prescribe—or manage other care for youth taking these medications under another provider's care—this is a must-take module given the prevalence of behavioral and mental health conditions among children and teens. Topics covered:
  • Treatment guidelines for ADHD, anxiety, and care of adolescents with depression in the primary care setting (recently updated ADHD, anxiety, & depression management guidelines)
  • Recommendations and emerging evidence for treatment of children and adolescents with ADHD, depression, and autism spectrum disorder and comorbid mental health diagnoses including:
    • ADHD + autism, ADHD + oppositional defiant disorder, ADHD + bipolar disorder, ADHD + obsessive-compulsive disorder, ADHD + Tourette syndrome
    • Depression + comorbid substance use disorders
    • ASD + behavioral disturbances, ASD + sleep disturbances
  • Management of depression in children and adolescents with medical illness
  • Recommendations and available evidence for pharmacologic treatment for children and adolescents with bipolar disorder, obsessive-compulsive disorder, agitation, and delirium
  • Adverse effects, FDA “black box warnings,” and medication interactions for psychopharmacologic agents used for treatment of children and adolescents with mental health diagnoses
  • Monitoring for and treatment of adverse effects associated with psychopharmacologic agents
For APRNs, RNs, or those familiar with pediatric pharmacology. View Content Outline

  • 7.5 pharmacology contact hours accredited by NAPNAP (7.5 related to psychopharmacology) (1.25 related to controlled substances).
  • Answers are due 150 days from order process date.
  • 41 questions.
  • What references are included?
    • 12 online PDF articles from 8 journals (a $300+ value) to support answering all 41 questions.
Sample Question

Q. A school-aged child diagnosed with social anxiety disorder is currently taking several medications for previously diagnosed medical conditions. When selecting an SSRI, which has a lower risk for potential drug interactions?

A. escitalopram
B. fluvoxamine
C. paroxetine
D. sertraline

Order #: SAE_PH_PSYCH21

Your Price: $85.00